About the brand

  • Name Meda AB
  • Products 6 pcs
View products

Meda AB

Meda AB

The company was founded in 1999 in Sweden and has since expanded its presence in more than 50 countries worldwide.

Key Areas of Focus:

  • Prescription Medications: Development and production of drugs for the treatment of various diseases.
  • Over-the-Counter Products: Non-prescription products, including health and nutrition aids.
  • Clinical Research: Conducting studies to develop new therapeutic solutions.
  • Registration and Logistics: Ensuring product registration and delivery to markets worldwide.

In 2016, Meda was acquired by Mylan, a global leader in pharmaceuticals. Meda continued to operate as a separate business unit under Mylan and later became part of Viatris, formed in 2020 from the merger of Mylan and Upjohn (a division of Pfizer).

Notable Products by Meda:

  • Allergodil: A treatment for allergic rhinitis and conjunctivitis.
  • Donabel (Dona): A medication for osteoarthritis.
  • Tiocid (Thioctacid): Used for treating diabetic polyneuropathy.
  • Legalon: A product supporting liver function.

Meda's products are available in over 120 countries, and the company continues to expand its presence in international markets.



OUR PARTNERS